Acetylsalicylic acid Terminated Phase 3 Trials for Constriction, Pathologic / Atherosclerosis / Stroke / Cerebral Infarctions Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02313909Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)
NCT00004728Aspirin Or Warfarin To Prevent Stroke